TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

2023127 citationsJournal Articlediamond Open Access

Authors

Yichuan Yuan · IHI Corporation (United States)

Wei He · IHI Corporation (United States)

Zhiwen Yang · IHI Corporation (United States)

Jiliang Qiu · IHI Corporation (United States)

Zhenkun Huang · Sun Yat-sen University

Yunxing Shi · Sun Yat-sen University

Lin Zhu ·

Abstract

Compared with TACE alone, combination therapy was safe enough and resulted in survival benefits. This is a promising treatment option for HCC patients with PVTT.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Cancer Mechanisms and Therapy Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

No poverty

Publication Details

Published in: International Journal of Surgery

Volume 109, Issue 5, pp. 1222-1230

DOI: 10.1097/js9.0000000000000256

Field-Weighted Citation Impact: 25.91